Suppr超能文献

海参多肽干预治疗后II型糖尿病小鼠尿液成分分析

Analysis of Urine Composition in Type II Diabetic Mice after Intervention Therapy Using Holothurian Polypeptides.

作者信息

Li Yanyan, Xu Jiajie, Su Xiurong

机构信息

School of Marine Science, Ningbo UniversityZhejiang, China.

Department of Food Science, Cornell UniversityIthaca, NY, United States.

出版信息

Front Chem. 2017 Jul 26;5:54. doi: 10.3389/fchem.2017.00054. eCollection 2017.

Abstract

Hydrolysates and peptide fractions (PF) obtained from sea cucumber with commercial enzyme were studied on the hyperglycemic and renal protective effects on db/db rats using urine metabolomics. Compared with the control group the polypeptides from the two species could significantly reduce the urine glucose and urea. We also tried to address the compositions of highly expressed urinary proteins using a proteomics approach. They were serum albumins, AMBP proteins, negative trypsin, elastase, and urinary protein, GAPDH, a receptor of urokinase-type plasminogen activator (uPAR), and Ig kappa chain C region. We used the electronic nose to quickly detect changes in the volatile substances in mice urine after holothurian polypeptides (HPP) fed, and the results show it can identify the difference between treatment groups with the control group without overlapping. The protein express mechanism of HPP treating diabetes was discussed, and we suggested these two peptides with the hypoglycemic and renal protective activity might be utilized as nutraceuticals.

摘要

利用尿液代谢组学研究了用商业酶从海参中获得的水解产物和肽组分(PF)对db/db大鼠的降血糖和肾脏保护作用。与对照组相比,这两个物种的多肽能显著降低尿葡萄糖和尿素水平。我们还尝试用蛋白质组学方法分析高表达尿蛋白的组成。它们是血清白蛋白、AMBP蛋白、负性胰蛋白酶、弹性蛋白酶、尿蛋白、甘油醛-3-磷酸脱氢酶(GAPDH)、尿激酶型纤溶酶原激活剂受体(uPAR)和Ig κ链C区。我们使用电子鼻快速检测喂食海参多肽(HPP)后小鼠尿液中挥发性物质的变化,结果表明它能识别治疗组与对照组之间的差异且无重叠。探讨了HPP治疗糖尿病的蛋白质表达机制,我们认为这两种具有降血糖和肾脏保护活性的肽可能可用作营养保健品。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdf3/5526924/3add311127b6/fchem-05-00054-g0001.jpg

相似文献

1
Analysis of Urine Composition in Type II Diabetic Mice after Intervention Therapy Using Holothurian Polypeptides.
Front Chem. 2017 Jul 26;5:54. doi: 10.3389/fchem.2017.00054. eCollection 2017.
2
Expression of Urokinase-type Plasminogen Activator Receptor and its Soluble Form in Type 2 Diabetic Kidney Disease.
Arch Med Res. 2019 Jul;50(5):249-256. doi: 10.1016/j.arcmed.2019.08.007. Epub 2019 Oct 5.
4
Effects of uPA on mesangial matrix changes in the kidney of diabetic rats.
Ren Fail. 2014 Sep;36(8):1322-7. doi: 10.3109/0886022X.2014.934694. Epub 2014 Jul 10.
5
Expression of urokinase plasminogen activator and its receptor during acute renal allograft rejection.
Kidney Int. 2003 Nov;64(5):1845-53. doi: 10.1046/j.1523-1755.2003.00261.x.
7
Inhibiting the urokinase-type plasminogen activator receptor system recovers STZ-induced diabetic nephropathy.
J Cell Mol Med. 2019 Feb;23(2):1034-1049. doi: 10.1111/jcmm.14004. Epub 2018 Nov 13.
9
Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy.
Kidney Int. 2005 Apr;67(4):1297-307. doi: 10.1111/j.1523-1755.2005.00207.x.
10
Hyperglycemia is associated with lower levels of urokinase-type plasminogen activator and urokinase-type plasminogen activator receptor in wound fluid.
J Diabetes Complications. 2014 Nov-Dec;28(6):844-9. doi: 10.1016/j.jdiacomp.2014.07.013. Epub 2014 Aug 7.

引用本文的文献

3
Research progress on the chemical components and biological activities of sea cucumber polypeptides.
Front Pharmacol. 2023 Oct 16;14:1290175. doi: 10.3389/fphar.2023.1290175. eCollection 2023.
4
Protein lysine four-carbon acylations in health and disease.
J Cell Physiol. 2024 Mar;239(3):e30981. doi: 10.1002/jcp.30981. Epub 2023 Feb 23.
6
2-hydroxyisobutyric acid (2-HIBA) modulates ageing and fat deposition in .
Front Mol Biosci. 2022 Nov 23;9:986022. doi: 10.3389/fmolb.2022.986022. eCollection 2022.

本文引用的文献

3
Omics databases on kidney disease: where they can be found and how to benefit from them.
Clin Kidney J. 2016 Jun;9(3):343-52. doi: 10.1093/ckj/sfv155. Epub 2016 Mar 21.
4
Association of Plasma Small-Molecule Intermediate Metabolites With Age and Body Mass Index Across Six Diverse Study Populations.
J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1507-1513. doi: 10.1093/gerona/glw031. Epub 2016 Mar 16.
5
The role of urinary peptidomics in kidney disease research.
Kidney Int. 2016 Mar;89(3):539-45. doi: 10.1016/j.kint.2015.10.010. Epub 2016 Jan 14.
6
Discovery and verification of urinary peptides in type 2 diabetes mellitus with kidney injury.
Exp Biol Med (Maywood). 2016 Jun;241(11):1186-94. doi: 10.1177/1535370216629007. Epub 2016 Feb 3.
8
Alterations of urinary metabolite profile in model diabetic nephropathy.
Biochem Biophys Res Commun. 2015 Jan 9;456(2):610-4. doi: 10.1016/j.bbrc.2014.12.003. Epub 2014 Dec 10.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验